Alembic’s associate company receives USFDA approval for cancer drug
Alembic Pharmaceuticals associate company Rhizen Pharmaceuticals has received approval from USFDA for cancer drug. According to a BSE release, “Rhizen Pharmaceuticals S.A. today announced that...